Gastrointestinal Stents In Global Market Will Expand At A CAGR Of 3.89% During The Period 2016 - 2020

Researchmoz added Most up-to-date research on "Gastrointestinal Stents In Global Market Will Expand At A CAGR Of 3.89% During The Period 2016 - 2020" to its huge collection of research reports.

Gastrointestinal stents consist of stents that include trans-hepatic, esophageal, biliary stents, pancreatic and duodenal stents. The stents are used during colorectal cancer, inflammatory bowel disease, GI bleeding, and other diseases. SEMSs are considered to be the most commonly used mesh cylindrical stents with large diameter to treat severe gastrointestinal conditions. The gastrointestinal stents are positioned under endoscopic view with fluoroscopic imaging guidance. The different types of stents used in gastrointestinal include esophageal stents, duodenal stents, and enteral colonic stents. Biliary stents are being used to treat biliary infection cholangitis and biliary decompression during benign and malignant conditions since the 1970s. The major obstructions in biliary stents include malignant and benign strictures, stenotic sphincters, obstructed endoprostheses, and bile duct stones

Technavios analysts forecast the global gastrointestinal stents market to grow at a CAGR of 3.89% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global gastrointestinal stents market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various gastrointestinal stents, which are segmented as follows:
Biliary and pancreatic stents
Esophageal stents
Duodenal stents
Colonic stents

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Gastrointestinal Stents Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
BD
Boston Scientific
ELLA-CS
Cook Medical
Medtronic
TaeWoong Medical

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=883451

Other prominent vendors
BVM Medical
ConMed
EndoChoice
Hobbs Medical
Merit Medical Systems
Olympus
Surgimedik

Market driver
Increasing incidence of gastrointestinal disorders
For a full, detailed list, view our report

Market challenge
Complications associated with gastrointestinal stents
For a full, detailed list, view our report

Market trend
Growing demand for nitinol material based gastrointestinal stents
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Browse More Details @ http://www.researchmoz.us/global-gastrointestinal-stents-market-2016-2020-report.html

Gastrointestinal Stents Global Market Including Key Vendors Such As BD, Boston Scientific, ELLA-CS, Cook Medical & Medtronic, 2016 - 2020

Researchmoz added Most up-to-date research on "Gastrointestinal Stents Global Market Including Key Vendors Such As BD, Boston Scientific, ELLA-CS, Cook Medical & Medtronic, 2016 - 2020" to its huge collection of research reports.

Gastrointestinal stents consist of stents that include trans-hepatic, esophageal, biliary stents, pancreatic and duodenal stents. The stents are used during colorectal cancer, inflammatory bowel disease, GI bleeding, and other diseases. SEMSs are considered to be the most commonly used mesh cylindrical stents with large diameter to treat severe gastrointestinal conditions. The gastrointestinal stents are positioned under endoscopic view with fluoroscopic imaging guidance. The different types of stents used in gastrointestinal include esophageal stents, duodenal stents, and enteral colonic stents. Biliary stents are being used to treat biliary infection cholangitis and biliary decompression during benign and malignant conditions since the 1970s. The major obstructions in biliary stents include malignant and benign strictures, stenotic sphincters, obstructed endoprostheses, and bile duct stones

Technavios analysts forecast the global gastrointestinal stents market to grow at a CAGR of 3.89% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global gastrointestinal stents market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various gastrointestinal stents, which are segmented as follows:
Biliary and pancreatic stents
Esophageal stents
Duodenal stents
Colonic stents

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Gastrointestinal Stents Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
BD
Boston Scientific
ELLA-CS
Cook Medical
Medtronic
TaeWoong Medical

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=883451

Other prominent vendors
BVM Medical
ConMed
EndoChoice
Hobbs Medical
Merit Medical Systems
Olympus
Surgimedik

Market driver
Increasing incidence of gastrointestinal disorders
For a full, detailed list, view our report

Market challenge
Complications associated with gastrointestinal stents
For a full, detailed list, view our report

Market trend
Growing demand for nitinol material based gastrointestinal stents
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Browse More Details @ http://www.researchmoz.us/global-gastrointestinal-stents-market-2016-2020-report.html

Gastrointestinal Stents In Global Market: Top manufacturers - BD, Boston Scientific, ELLA-CS, Cook Medical, Medtronic & TaeWoong Medical

Researchmoz added Most up-to-date research on "Gastrointestinal Stents In Global Market: Top manufacturers - BD, Boston Scientific, ELLA-CS, Cook Medical, Medtronic & TaeWoong Medical" to its huge collection of research reports.

This report studies Gastrointestinal Stents in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
BD
Boston Scientific
ELLA-CS
Cook Medical
Medtronic
TaeWoong Medical
BVM Medical
ConMed
EndoChoice
Hobbs Medical
Merit Medical Systems
Olympus
Surgimedik

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Gastrointestinal Stents in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III

Split by application, this report focuses on consumption, market share and growth rate of Gastrointestinal Stents in each application, can be divided into
Application 1
Application 2
Application 3

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=898497

Table of Contents

Global Gastrointestinal Stents Market Research Report 2016
1 Gastrointestinal Stents Market Overview
1.1 Product Overview and Scope of Gastrointestinal Stents
1.2 Gastrointestinal Stents Segment by Type
1.2.1 Global Production Market Share of Gastrointestinal Stents by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Gastrointestinal Stents Segment by Application
1.3.1 Gastrointestinal Stents Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Gastrointestinal Stents Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Gastrointestinal Stents (2011-2021)

2 Global Gastrointestinal Stents Market Competition by Manufacturers
2.1 Global Gastrointestinal Stents Production and Share by Manufacturers (2015 and 2016)
2.2 Global Gastrointestinal Stents Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Gastrointestinal Stents Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Gastrointestinal Stents Manufacturing Base Distribution, Sales Area and Product Type
2.5 Gastrointestinal Stents Market Competitive Situation and Trends

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=898497

Need And Demand For Better Treatments In Gastrointestinal Drug Global Market: Key Trends, Analysis, Size, Volume, Share, Growth and Forecast To 2017 - 2022

ResearchMoz presents this most up-to-date research on "Need And Demand For Better Treatments In Gastrointestinal Drug Global Market: Key Trends, Analysis, Size, Volume, Share, Growth and Forecast To 2017 - 2022".

Disease and disorders involving the gastrointestinal system are among the most common conditions encountered worldwide, and many of them can have a significant impact on quality of life. The direct and indirect socio-economic burden associated with gastrointestinal disorders is profound. The direct costs of medical consultations and treatments in the US for gastroesophageal reflux disease alone are estimated to amount to $9.3 billion, while the indirect costs due to absenteeism and impairment in work performance total $75 billion (Chait, 2010).

Despite the significant global socio-economic burden, many gastrointestinal disorders are still poorly understood, and there is a significant unmet need for novel, safe and effective therapies, as treatment options are often lacking, causing many patients to be dissatisfied with their treatment. The unmet need and demand for better treatments and the high prevalence of digestive conditions make the gastrointestinal market an attractive candidate for therapeutic development.

This report covers all gastrointestinal disorders, but there is a particular focus on three key diseases: gastroesophageal reflux disease, irritable bowel syndrome and inflammatory bowel disease. The global gastrointestinal market was valued at $35.7 billion in 2015 and is projected to grow at a compound annual growth rate (CAGR) of 4.45%, reaching $48.4 billion in 2022. Proton pump inhibitors (PPIs) and tumor necrosis factor (TNF)-? inhibitors generate the largest revenues and continue to retain commercial prominence. Key drivers of market growth will be the uptake of recently approved premium products, rising prevalence, and promising late-stage products, including a number of biologic therapies that are expected to be highly valuable.

Scope

The gastrointestinal market landscape is expected to change substantially with the advent of promising novel pipeline products.

There are 937 gastrointestinal pipeline products in active development, of which small molecules and biologics account for 53% and 38%, respectively.

• Which molecular targets are most prominent within the pipeline?
• How do the key indications differ in terms of molecule type?
• How does the composition of the pipeline compare with that of the existing market?
• What mechanisms of action are most common for pipeline drugs?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=855887

Global revenue for the gastrointestinal market is forecast to grow at a CAGR of 4.45%, from $35.7 billion in 2015 to $48.4 billion in 2022.

• Which products will be the biggest drivers for market growth?
• Will the current market leaders retain their dominance over the forecast period, and how is their revenue share of the gastrointestinal market set to change?
• What CAGR will these companies register in the forecast period?

Reasons to buy

This report will allow you to - 

• Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis and the treatment options available at each stage of diagnosis.
• Visualize the composition of the gastrointestinal market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players.
• Analyze the gastrointestinal pipeline, stratifying it by stage of development, molecule type and molecular target and providing a granular breakdown across key indications.
• Understand the growth in patient epidemiology and market revenue for the gastrointestinal market globally and across the key players and product types.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=855887